Ganglion blockade does not prevent cortisol-induced hypertension in man

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 4, 2005, Pages 294-296

  Williamson, Paula M ^a   Sim, Hom Tam ^a   Kelly, John J ^a,c   Whitworth, Judith A ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Australian National University   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

Author keywords

Blood pressure; Cortisol; Ganglion blockade; Humans; Steroids

Indexed keywords

HYDROCORTISONE; TRIMETAPHAN;

ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; GANGLION BLOCK; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; PHARMACOLOGICAL BLOCKING; SYMPATHETIC TONE;

AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIONIC BLOCKERS; HEART RATE; HUMANS; HYDROCORTISONE; HYPERTENSION; MALE; TRIMETHAPHAN;

EID: 17844377555     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04220.x     Document Type: Article

References (17)

1. Kelly JJ, Mangos G, Williamson PM, Whitworth JA. Cortisol and hypertension. Clin. Exp. Pharmacol. Physiol. 1998; 25: S51-6.
2. Sudhir K, Jennings GL, Esler MD et al. Hydrocortisone-induced hypertension in humans: Pressor responsiveness and sympathetic function. Hypertension 1989; 13: 416-21.
3. Tam SH, Kelly JJ, Williamson PM, Whitworth JA. Reflex sympathetic functions in cortisol-induced hypertension in humans. Clin. Exp. Hypertens. 1997; 19: 479-93.
4. Tam SH, Williamson PM, Kelly JJ, Whitworth JA. Autonomic blockade amplifies cortisol-induced hypertension in man. Clin. Exp. Pharmacol. Physiol. 1997; 24: 31-3.
5. Whitworth JA, Williamson PM, Brown MA, Morris MJ. Neuropeptide Y in cortisol induced hypertension in man. Clin. Exp. Pharmacol. Physiol. 1994; 21: 435-8.
6. Macefield VG, Williamson PM, Wilson LR, Kelly JJ, Gandevia SC, Whitworth JA. Muscle sympathetic vasoconstrictor activity in hydrocortisone-induced hypertension in humans blood. Blood Pressure 1998; 7: 215-22.
7. Whitworth JA, Schyvens CG, Zhang Y, Mangos GJ, Kelly JJ. Glucocorticoid-induced hypertension: From mouse to man. Clin. Exp. Pharmacol. Physiol. 2001; 28: 993-6.
8. Cunha RS, Cabral AM, Vasquez EC. Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats. Am. J. Hypertens. 1993; 6: 806-9.
9. Ahluwalia A, Cellek S. Regulation of the cardiovascular system by non-adrenergic non-cholinergic nerves. Curr. Opin. Nephrol. Hypertens. 1997; 6: 74-9.
10. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat. Med. 1990; 9: 811-18.
11. Randall LO, Peterson WG, Lehmann G. The ganglion blocking action of thiophanium derivatives. J. Pharm. Exp. Ther. 1949; 97: 48-57.
12. Spence CD, Mathai M, Mills EH, Coghlan JP, Whitworth JA, Scoggins BA. Centrally mediated increased sympathetic activity is not important in the genesis of ACTH-induced hypertension in sheep. Clin. Exp. Pharmacol. Physiol. 1989; 16: 607-19.
13. Spence CD, Coghlan JP, Denton DA et al. Role of the autonomic nervous system, renin-angiotensin system, and arginine vasopressin during the onset and maintenance of ACTH hypertension in sheep. Can. J. Physiol. Pharmacol. 1987; 65: 1739-51.
14. Li M, Whitworth JA. Role of the sympathetic nervous system in the onset of hypertension in the rat. The effect of 6-OH dopamine. Clin. Exp. Pharmacol. Physiol. 1991; 18: 197-204.
15. Tonolo G, Soro A, Madeddu P et al. Effect of chronic intracerebroventricular dexamethasone on blood pressure in normotensive rats. Am. J. Physiol. 1993; 264: 843-7.
16. Gomez-Sanchez EP, Venkataraman MT, Thwaites D, Fort C. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am. J. Physiol. 1990; 258: 649-53.
17. Van den Berg DTWH, de Kloet ER, van Dijken HH, de Jong W. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure. Endocrinology 1990; 126: 118-24.